Download PDF
Thromb Haemost 2003; 89(03): 573-582
DOI: 10.1055/s-0037-1613389
New Technologies and Diagnostic Tools
Schattauer GmbH

Fibrin-based biomaterials to deliver human growth factors

Catalina Wong
1   BioSurgery Group, BioScience R&D, Baxter Healthcare Corporation, California, USA
,
Elisabeth Inman
1   BioSurgery Group, BioScience R&D, Baxter Healthcare Corporation, California, USA
,
Reiner Spaethe
1   BioSurgery Group, BioScience R&D, Baxter Healthcare Corporation, California, USA
,
Sam Helgerson
1   BioSurgery Group, BioScience R&D, Baxter Healthcare Corporation, California, USA
› Author Affiliations
Further Information

Publication History

Received 30 October 2002

Accepted after revision 12 December 2002

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

Summary

Fibrin-based biomaterial preparations can be used as provisional growth matrices for cells important in tissue repair during wound healing in vivo. Their efficacy can be enhanced by including bioactive agents that promote specific cellular responses. This study examined the controlled delivery of the angiogenic growth factors bFGF, VEGF165, and VEGF121 using biomatrix preparations prepared from Fibrin Sealant product components. The growth factors were added prior to formation of the Fibrin Sealant clots, and the release kinetics of the proteins from the clots measured. The results indicated that the proteins were released from the clots more slowly in the order bFGF << VEGF165 < VEGF121. The biologic activity of the growth factors delivered from Fibrin Sealant clots was established by assaying growth stimulation of human microvascular endothelial cells (HMVEC) and angiogenesis in the chicken embryo chorioallantoic membrane (CAM) model of neovascularization. In the latter assay, clots containing bFGF, VEGF165, or V EGF121 all displayed angiogenic activity. However, delivery of either bFGF, VEGF165, or VEGF121 alone resulted in a significant percentage of clots becoming filled with blood, indicating that the newly developing vessels invading the clots were leaky and immature. In contrast, this hemorrhaging behavior did not occur with delivery of combinations, e.g., (VEGF165 + VEGF121) or (VEGF165 + bFGF), indicating that the vessels were more mature than those produced in response to single growth factors. Thus, delivering a combination of growth factors constituted an improvement over the delivery of individual growth factors for enhancing neovascularization.

Part of this research was presented at the joint meetings of the 16th International Congress of the International Society of Fibrinolysis and Proteolysis and the 17th International Fibrinogen Workshop of the International Fibrinogen Research Society held in Munich, Germany.

Keywords

Fibrin(ogen) - fibrin sealant - growth factors - angiogenesis - wound healing
 

  • References

  • 1 Schlag G. The Importance of Fibrin in Wound Repair. In: Fibrin Sealant in Operative Medicine Otorhinolaryngology. G Schlag and H Redl eds: Springer-Verlag 1986; 3-12.
    PubMedGoogle Scholar
  • 2 Clark RAF. Fibrin and wound healing. Ann N Y Acad Sci 2001; 936: 355-67.
    CrossrefPubMedGoogle Scholar
  • 3 Hench LH, Polak JM. Third-generation biomedical materials. Science 2002; 295: 1014-7.
    CrossrefPubMedGoogle Scholar
  • 4 Mac Phee MJ, Singh MP, Brady Jr. R, Akhyani N, Liau G, Lasa Jr. C, Hue C, Best A, Drohan W. Fibrin Sealant: A Versatile Delivery Vehicle for Drugs and Biologics. In: Surgical Adhesives and Sealants – Current Technology and Applications. DH Sierra and R Saltz eds: Technomic Publishing Co 1996; 109-20.
    PubMedGoogle Scholar
  • 5 Kim WJH. Cellular Signaling in Tissue Regeneration. Yonsei Med J 2000; 41: 692-703.
    CrossrefPubMedGoogle Scholar
  • 6 Pierce GF, Mustoe TA. Pharmacologic enhancement of wound healing. Annu Rev Med 1995; 46: 467-81.
    CrossrefPubMedGoogle Scholar
  • 7 Madri JA, Sankar S, Romanic AM. Angiogenesis. In: The Molecular and Cellular Biology of Wound Repair. RAF Clark ed: Plenum Press 1996; 355-72.
    PubMedGoogle Scholar
  • 8 Folkman J, Klagsbrun M. Angiogenic Factors. Science 1987; 235: 442-8.
    CrossrefPubMedGoogle Scholar
  • 9 Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J Physiol Cell Physiol 2001; 280: 1358-66.
    CrossrefPubMedGoogle Scholar
  • 10 Carmeliet P, Collen D. Molecular analysis of blood vessel formation and disease. Am J Physiol 1997; 273: H2091-H2104.
    PubMedGoogle Scholar
  • 11 Martin P. Wound healing – aiming for perfect skin regeneration. Science 1997; 276: 75-81.
    CrossrefPubMedGoogle Scholar
  • 12 Thompson WD, McNally SJ, Ganesalingam N. Wound Healing, Fibrin, and Angiogenesis. In: Molecular, Cellular, and Clinical Aspects of Angiogenesis. ME Maragoudakis ed: Plenum Press 1996; 161-72.
    PubMedGoogle Scholar
  • 13 Nicosia RF, Ottinetti A. Modulation of micro-vascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 1990; 26: 119-128.
    CrossrefPubMedGoogle Scholar
  • 14 van Hinsbergh V, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci 2001; 936: 426-37.
    PubMedGoogle Scholar
  • 15 Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998; 273: 7554-9.
    CrossrefPubMedGoogle Scholar
  • 16 Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000; 96: 3772-8.
    PubMedGoogle Scholar
  • 17 Campbell PG, Durham SK, Hayes JD, Suwanichkul A, Powell DR. Insulin-like growth factor-binding protein-3 binds to fibrinogen and fibrin. J Biol Chem 1999; 274: 30215-21.
    CrossrefPubMedGoogle Scholar
  • 18 Sierra DH. Fibrin Sealant adhesive systems: a review of their chemistry, material properties, and clinical applications. J Biomater Appl 1993; 7: 309-52.
    CrossrefPubMedGoogle Scholar
  • 19 Jackson MR, MacPhee MJ, Drohan WN, Alving BM. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis 1996; 7: 737-46.
    CrossrefPubMedGoogle Scholar
  • 20 Chibber BA, Deutsch DG, Mertz ET. Affinity chromatography of plasminogen. Methods Enzmol 1974; 34: 424-32.
    PubMedGoogle Scholar
  • 21 Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 1977; 20: 1-5.
    CrossrefPubMedGoogle Scholar
  • 22 Houck K, Leung D, Rowland A, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 23031-6037.
    PubMedGoogle Scholar
  • 23 Lobb RR. Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor. Biochemistry 1988; 27: 2572-8.
    CrossrefPubMedGoogle Scholar
  • 24 Sahni A, Baker C, Sporn L, Francis CW. Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation. Thromb Haemost 2000; 83: 736-41.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002; 91: 25-31.
    CrossrefPubMedGoogle Scholar
  • 26 Keyt BA, Berleau LT, Nguyen HV, Chen H, Heisohn H, Vandlen R, Ferrara N. The car-boxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996; 271: 7788-95.
    CrossrefPubMedGoogle Scholar
  • 27 Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Farrara N. Vascular endothelial growth factor is a secreted angiogenic mito-gen. Science 1989; 246: 1306-8.
    CrossrefPubMedGoogle Scholar
  • 28 Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947-54.
    PubMedGoogle Scholar
  • 29 Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993; 4: 1317-26.
    CrossrefPubMedGoogle Scholar
  • 30 Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagburn MN. Endothelial cell-derived basic fibroblast growth factor, synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acsd Sci USA 1987; 84: 2292-6.
    PubMedGoogle Scholar
  • 31 Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-9.
    CrossrefPubMedGoogle Scholar
  • 32 Villaschi S, Nicosia RF. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 1993; 143: 181-90.
    PubMedGoogle Scholar
  • 33 Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993; 7: 52-62.
    CrossrefPubMedGoogle Scholar
  • 34 Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77: 956-64.
    CrossrefPubMedGoogle Scholar
  • 35 Parsons-Wingerter P, Elliott KE, Clark I J, Farr AG. Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree. Arterioscler Thromb Vasc Biol 2000; 20: 1250-6.
    CrossrefPubMedGoogle Scholar
  • 36 Wilting J, Christ B, Bokeloh M, Weich HA. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 1993; 274: 163-72.
    CrossrefPubMedGoogle Scholar
  • 37 Hasimoto J, Kurosaka M, Yoshiya S, Hirohata K. Meniscal repair using fibrin sealant and endothelial cell growth factor. Am J Sports Med 1992; 20: 537-41.
    CrossrefPubMedGoogle Scholar
  • 38 Albes JM, Klenzner T, Kotzerke J, Thiedemann KU, Scafers H-J, Borst H-G. Improvement of tracheal autograft revascularization by means of fibroblast growth factor. Ann Thorac Surg 1994; 57: 444-9.
    CrossrefPubMedGoogle Scholar
  • 39 Quirinia A, Viidik A. The effect of recombinant basic fibroblast growth factor (bFGF) in fibrin adhesive vehicle on the healing of ischemic and normal incisional skin wounds. Scand J Plast Reconstr Hand Surg 1998; 32: 9-18.
    CrossrefPubMedGoogle Scholar
  • 40 Nakanishi R, Hashimoto M, Yasumoto K. Improved airway healing using basic fibroblast growth factor in a canine tracheal auto-transplantation model. Ann Surg 1998; 227: 446-54.
    CrossrefPubMedGoogle Scholar
  • 41 Greisler HP. Growth factor release from vascular grafts. J Controlled Release 1996; 39: 267-80.
    CrossrefPubMedGoogle Scholar
  • 42 Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF Gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
    CrossrefPubMedGoogle Scholar